|
|
 |
HEALTH-DISEASE-MALARIA-VACCINE-FILES
(FILES) -- This undated file photo courtesy of Sanaria, Inc. of Rockville, Maryland, shows Malaria infected mosquitoes ready for dissection in the lab's manufacturing facility during vaccine production. British drug maker GlaxoSmithKline (GSK) said on October 8, 2013 it hoped to get the green light for a prototype vaccine against malaria after trials showed it offered children a partial shield against the disease. Results for the Phase III stage of the closely-followed RTS,S vaccine were unveiled at a conference in Durban, South Africa, gathering experts on malaria in Africa. AFP PHOTO / Sanaria Inc. / Robert Thompson
= RESTRICTED TO EDITORIAL USE / MANDATORY CREDIT / AFP PHOTO / Sanaria Inc. / Robert Thompson / NO MARKETING / NO ADVERTISING CAMPAIGNS / DISTRIBUTED AS A SERVICE TO CLIENTS =
|
|
|
|
Detalii fotografie |
| Loc: |
|
Rockville, Maryland, UNITED STATES |
|
| Sursa: |
|
AFP / Mediafax Foto |
|
| Fotograf: |
|
Adam M. Richman |
|
| Data: |
|
8 Octombrie 2013 |
|
| Dimensiuni: |
|
4900 x 3250 (1.47 MB) |
|
|
|
|
|
|